learndrugs
Integumentary

Cellulitis & Necrotizing Fasciitis

Erysipelas High-yield Verified · Oct 2026

Cellulitis is an acute spreading bacterial infection of the dermis and subcutaneous tissue. Necrotizing fasciitis is an aggressive skin and soft tissue infection causing muscle fascia and subcutaneous tissue necrosis, and it is a surgical emergency.

The disorder behind marking the border with a pen, behind pain out of proportion, behind tenderness that extends past the red edge, behind a LRINEC score that must never delay a surgeon, and behind the leg that has quietly stopped hurting.

What’s going wrong in the body

The normal physiology, where it fails, and why the body’s compensation backfires.

01 One doorway, three destinations

Cellulitis is "an acute, spreading bacterial infection of the dermis and subcutaneous tissue, marked by erythema, warmth, swelling, and tenderness." Bacteria breach the epidermis and trigger a cytokine and neutrophil response with antimicrobial peptide production and keratinocyte proliferation. The organisms are predictable: Streptococcus pyogenes and Staphylococcus aureus most commonly cause it, with methicillin-resistant S. aureus, Pasteurella multocida after animal bites, Vibrio vulnificus after water exposure and Pseudomonas aeruginosa in diabetics appearing in immunocompromised patients. The whole etiology is the portal of entry: "any cause of skin barrier breakdown, such as skin injuries, surgical incisions, intravenous site punctures, fissures between toes, insect bites, animal bites, and other skin infections." The tinea pedis between the toes is the commonest unrecognized doorway into a leg cellulitis, and treating it is part of preventing the next episode.

Erysipelas is the shallower cousin, and the depth explains the border. It is "a more superficial infection affecting the upper dermis and superficial lymphatic system." Because those lymphatics are anatomically bounded, the infection stops at a visible line: erysipelas shows "bright red erythema, elevation of the affected skin, and well-demarcated borders." Cellulitis, spreading through looser deep dermis and subcutaneous tissue with no such boundary, appears with poorly demarcated borders… mildly erythematous and flat. Raised and sharply edged is erysipelas; flat and blurry-edged is cellulitis — and the distinction matters because their first-line drugs differ.

Necrotizing fasciitis is the third destination, and its anatomy explains everything that makes it dangerous. It is defined as an infection causing "muscle fascia and subcutaneous tissue necrosis." It travels along fascial planes beneath the skin, destroying them and thrombosing the vessels that cross them — "extensive superficial fascial necrosis… thrombosed" vessels — before the skin above has changed. That head start is why pain is out of proportion to what you can see, why tenderness extends past the visible red border, and why early differentiation from cellulitis is genuinely difficult. The same fascial destruction takes out cutaneous nerves, producing "dysesthesia or paresthesia" and then "anesthesia… in some areas" — so a cellulitis that stops hurting where it used to hurt is not improving. Beyond that lies toxic shock: superantigen toxins "bypass the normal pathway for activation of T cells resulting in over-activation of cytokines and inflammatory cells," causing systemic inflammation and organ dysfunction via capillary leak.

Depth decides the diagnosis. The fascial route is the dangerous one because the infection outruns the skin, which is exactly why the earliest signs are about pain rather than appearance.

02 The IDSA algorithm — purulent or not, then how sick

The 2014 Infectious Diseases Society of America guideline (cited, not quoted here) organizes skin and soft tissue infection on two axes — purulent versus nonpurulent, then how sick the patient is — and the StatPearls chapter teaches the same split. Clinicians must determine "the severity and type of cellulitis (purulent vs nonpurulent)." Nonpurulent, no systemic signs: "antibiotics effective against streptococcal species," with MSSA also considered — cephalexin 500 mg every 6 hours for at least 5 days. Systemically unwell: admit and give intravenous therapy that first targets group A strep. Purulent, or MRSA risk: add MRSA-active cover.

The purulent arm has a treatment that is not a drug: a skin abscess "may need be drained to get rid of the pus," usually through "a small operation to make a cut in the skin." A drainable abscess needs a scalpel, not a script. On the nonpurulent arm the escalation is by coverage: no MRSA risk — "intravenous cefazolin, then switch to oral cephalexin"; MRSA risk — "start with intravenous vancomycin and later transition to oral trimethoprim-sulfamethoxazole"; immunocompromised — "combining vancomycin with piperacillin-tazobactam or using a carbapenem."

Admission criteria are explicit. Hospitalize for "systemic signs of infection (defined as 2 or more systemic inflammatory response criteria, such as fever above 38° C, heart rate greater than 90 beats/min, respiratory rate over 20 breaths/min…)," and consider admission for those who "have failed outpatient treatment, are immunocompromised, exhibit rapidly progressing erythema, are unable to tolerate oral medications, or have cellulitis overlying or near an indwelling medical device."

Two questions settle most decisions: is there pus to drain, and is the patient systemically ill. Erysipelas sits outside the ladder with its own first-line drug, because it is essentially a streptococcal disease.

03 Necrotizing fasciitis — recognizing it, and refusing to be delayed

The finding that outranks everything is quoted: "necrotizing infections are more commonly present with excruciating pain out of proportion to presenting symptoms," and "suspicion should be high for necrotizing fasciitis in intense pain." The second-best sign is tenderness to palpation beyond the erythematous border — which is useful precisely because it maps the fascial spread the skin has not caught up with. Alongside it: crepitus, from gas-forming organisms in polymicrobial infection; dysesthesia, paresthesia and then anesthesia in some areas; and skin that transitions to "an erythematous, reddish-purple to bluish-gray hue," "swollen, shiny, and warm," with skin breakdown… in 3 to 5 days accompanied by bullae and cutaneous gangrene. Systemically, advanced stages… are characterized by fever, tachycardia, and sepsis.

The classification matters for the drugs. Type I is polymicrobial — mixed aerobic and anaerobic bacteria including gram-positive species (Streptococcus, Staphylococcus aureus) and gram-negative organisms (E. coli, Pseudomonas aeruginosa), plus anaerobes (Bacteroides, Clostridium). Type II is monomicrobial — group A Streptococcus, often with S. aureus co-infection. Types III and IV are gram-negative organisms and Clostridium species from marine or environmental exposure. Fournier gangrene is "a rare and rapidly progressive form of necrotizing fasciitis" of the perineal, anal, scrotal and genital regions, and typically presents as Type I. Its risk profile is specific: diabetes in 20% to 70% of cases and chronic alcohol use in 25% to 50%.

The LRINEC score exists, and the reason to teach it is its limit. Its components: C-reactive protein under 150 mg/L scores 0 and over 150 scores 4; white cell count under 15 scores 0, 15 to 25 scores 1, over 25 scores 2; hemoglobin over 13.5 g/dL scores 0, 11 to 13.5 scores 1, under 11 scores 2; sodium of 135 mmol/L or above scores 0 and under 135 scores 2; creatinine of 1.6 mg/dL or less scores 0 and over 1.6 scores 2; glucose of 180 mg/dL or less scores 0 and over 180 scores 1. "A score of 6 has a positive predictive value of 92% and a negative predictive value of 96%. A score of 8 or greater represents a 75% risk of necrotizing infection." And then the sentence that governs its use: "the diagnosis of NSTIs is still primarily clinical," and "no lab or imaging test should delay surgical intervention." A low score in a patient with pain out of proportion does not rule this out. The score supports suspicion; it never overrides it.

Every red flag leads to the same box. The score sits to one side on purpose: it can raise your suspicion, and it is never allowed to lower it below what the patient in front of you is telling you.

Causes & risk factors

Modifiable factors are teaching targets — the patient can act on them.

Any break in the skin — this is the whole etiology. "Skin injuries, surgical incisions, intravenous site punctures, fissures between toes, insect bites, animal bites, and other skin infections" modifiable Chronic or untreated tinea pedis — listed as a risk factor in its own right, and the commonest unrecognized doorway into a leg cellulitis. It is a target for preventing the next episode rather than an incidental finding modifiable Diabetes mellitus — a cellulitis risk factor, a necrotizing fasciitis risk factor, and present in 20% to 70% of Fournier gangrene cases modifiable Venous insufficiency, peripheral arterial disease and lymphedema. Lymphatic edema is named the "major risk factor" for erysipelas specifically modifiable Alcohol use disorder and liver cirrhosis — "the majority of patients [with necrotizing fasciitis] have diabetes and a history of alcoholism," and chronic alcohol use appears in 25% to 50% of Fournier cases modifiable Immunosuppression, including HIV and immunosuppressant medications, and recent surgical wounds For Fournier gangrene specifically — obesity, recent urological procedures, peripheral vascular disease, and a controversial association with SGLT2 inhibitor use; anatomic sources include urinary tract infection, bowel or perianal disease, cutaneous trauma or minor skin breakdown Poor prognostic factors in necrotizing fasciitis: advanced age, uncontrolled diabetes, immunosuppression, and delayed surgery. Three of the four are fixed on arrival; the fourth is the one the team controls modifiable Exposure-specific organisms that change the drug: Pasteurella multocida after animal bites, Vibrio vulnificus after water exposure, Pseudomonas aeruginosa in diabetics, and Clostridium or gram-negatives from marine or environmental exposure in type III and IV necrotizing infection Recurrence itself — annual cellulitis recurrence runs 8% to 20%, with overall recurrence "as high as 49%," At 3 to 4 episodes per year, prophylaxis becomes a guideline-supported option modifiable

Signs & symptoms

Each finding tied to the mechanism that produces it — and the triage it calls for.

A unilateral, flat, poorly demarcated area of warm, swollen, tender erythema Hold & notify
Why: The sourced cellulitis presentation. It spreads through deep dermis and subcutaneous tissue with no anatomical boundary, so the edge is blurry. Cellulitis "is most often unilateral and rarely (if ever) presents bilaterally" — which makes laterality a real discriminator, not a detail.
A bright red, raised, sharply demarcated patch that developed quickly Hold & notify
Why: Erysipelas. It sits in the upper dermis and superficial lymphatics, which are anatomically bounded, so the infection stops at a visible line. It matters because the first-line drug differs: penicillin monotherapy for erysipelas, cephalexin for mild nonpurulent cellulitis.
Fever, malaise and fatigue with a spreading red limb Report immediately
Why: "Constitutional symptoms… reflecting systemic involvement in moderate to severe cases." Two or more systemic inflammatory response criteria is the sourced admission threshold, so these findings move the patient from an outpatient to an inpatient problem.
Vesicles, bullae, or peau d'orange around hair follicles Hold & notify
Why: Sourced additional cellulitis findings — the orange-peel appearance comes from edema tethered around follicles. Bullae in particular are on the patient return-precaution list and also appear in necrotizing infection, so they always warrant a look rather than reassurance.
Excruciating pain out of proportion to what the skin looks like Report immediately
Why: The single most important finding on this page. "Suspicion should be high for necrotizing fasciitis in intense pain." The infection is destroying fascia beneath skin that has not changed yet, so the pain is reporting damage the examination cannot see.
Tenderness to palpation beyond the erythematous border Report immediately
Why: The most useful bedside sign after the pain, because it maps the fascial spread directly. The red edge shows where the skin is involved; the tenderness shows where the fascia is. When the second is larger than the first, the infection is travelling underneath.
Crepitus Report immediately
Why: Subcutaneous gas from gas-forming organisms in polymicrobial type I infection. It is a classic Fournier feature, and ultrasound detection of subcutaneous gas is described as a pathognomonic finding. It is never a reason to order more tests before calling a surgeon.
An area that has gone numb, or where pain has stopped Report immediately
Why: A cellulitis that stops hurting where it used to hurt is not improving. The fascial destruction takes out cutaneous nerves, producing "dysesthesia or paresthesia" and then "anesthesia… in some areas." This is the most counterintuitive deterioration sign in the whole disorder.
Skin turning reddish-purple to bluish-gray, shiny and swollen, with bullae and breakdown at 3 to 5 days late Report immediately
Why: The sourced evolution of necrotizing fasciitis skin changes. By the time the skin looks like this the diagnosis has usually been available for a while through pain and tenderness — which is the argument for acting on the earlier findings rather than waiting for the appearance to confirm them.
Pain disproportionate to visible findings in the perineal, scrotal or genital region, with foul-smelling discharge Report immediately
Why: Fournier gangrene, whose early signs — itching, tenderness, edema, erythema — are easily confused with cellulitis. Mortality is about 40% despite modern treatment, and delays beyond 12 hours significantly increase it.
Fever, hypotension and a sunburn-like rash with organ dysfunction Report immediately
Why: Toxic shock syndrome — "an acute-onset illness characterized by fever, hypotension, sunburn-like rash, and end-organ damage," classically "a diffuse, blanching, macular erythroderma" that typically desquamates one to two weeks later, with renal, hepatic and coagulation involvement.
No improvement in a treated cellulitis at 48 hours Hold & notify
Why: On the correct antibiotic, patients "can expect to notice an improvement in signs and symptoms" within 24 to 48 hours. There is "approximately an 18% failure rate with initial antibiotic treatment," so failure to improve means reconsider the diagnosis, the organism, or whether this was ever cellulitis.

Diagnostics

Test In this disorder Normal
Diagnosis of cellulitis Cellulitis is common — about 50 cases per 1,000 patient-years, over 14 million US cases annually, 650,000 hospitalizations. That frequency is also why the mimics matter: many conditions look similar, and the sourced safeguard is the 48-hour reassessment rather than a confirmatory test Clinical. "Cellulitis is diagnosed clinically based on spreading erythematous inflammation of the deep dermis and subcutaneous tissue," requiring two of the four criteria: warmth, erythema, edema, or tenderness StatPearls, Cellulitis —
Blood cultures The temptation to culture everything is strong in an infection this common, and the yield does not justify it. For Fournier gangrene the workup is different and broader: complete blood count, metabolic panel, lactate, and blood cultures Not routine. "Consider blood cultures only in patients who are immunocompromised, have experienced an immersion injury, or have had animal bites," or who have signs of systemic infection StatPearls, Cellulitis —
Imaging in cellulitis Imaging has one clear role in this disorder family, and it is not in uncomplicated cellulitis: it is to confirm a suspected deep vein thrombosis, which requires ultrasound confirmation. The discriminator that prompts that scan is systemic — DVT "rarely manifests with fevers or leukocytosis" Not routine either. The IDSA practice guidelines "recommend against imaging the infected area except in patients with febrile neutropenia" IDSA, as reported by StatPearls —
LRINEC score components The limitation is the reason to teach the score at all: "the diagnosis of NSTIs is still primarily clinical," and "no lab or imaging test should delay surgical intervention." A low score in a patient with pain out of proportion does not rule this out C-reactive protein under 150 mg/L = 0, over 150 = 4. White cells under 15 = 0, 15 to 25 = 1, over 25 = 2. Hemoglobin over 13.5 g/dL = 0, 11 to 13.5 = 1, under 11 = 2. Sodium 135 mmol/L or above = 0, under 135 = 2. Creatinine 1.6 mg/dL or less = 0, over 1.6 = 2. Glucose 180 mg/dL or less = 0, over 180 = 1 StatPearls, Necrotizing Fasciitis A score of 6 has a positive predictive value of 92% and a negative predictive value of 96%. A score of 8 or greater represents a 75% risk of necrotizing infection
Imaging in necrotizing infection The same rule governs all of it: imaging should never delay surgery in obvious cases, and "no lab or imaging test should delay surgical intervention." Imaging is for the uncertain case, never for the convinced one CT offers "greater sensitivity than plain film," and plain X-rays have "no value. For Fournier gangrene, CT has 88.5% sensitivity and 93.3% specificity, showing fat stranding, emphysema, fascial thickening"; ultrasound detects subcutaneous gas (pathognomonic finding) StatPearls, Necrotizing Fasciitis and Fournier Gangrene —
The finger test This is the sourced operative finding, and it is worth knowing because a more colourful phrase is widely taught in its place. No source fetched for this page uses the words "dishwater" or "dirty dishwater fluid," so that description is not used here. Histopathology shows "extensive superficial fascial necrosis" with thrombosed vessels "Sometimes, under local anesthesia, one may probe the area with a finger for signs of necrotizing tissue. In most cases, the necrotic tissue can be penetrated with little resistance" StatPearls, Necrotizing Fasciitis —
Distinguishing the mimics Bilateral plus chronic plus scaling plus hyperpigmented equals stasis dermatitis, not cellulitis — and treating stasis dermatitis with antibiotics is a common error. Note what is deliberately not quantified here: no fetched source gives a percentage for how often cellulitis is misdiagnosed, so none is stated Deep vein thrombosis — unilateral "tenderness, erythema, warmth, and edema" but it "rarely manifests with fevers or leukocytosis," and needs ultrasound. Venous stasis dermatitis — "a long-standing, bilateral, inflammatory dermatosis" of the medial malleoli with "erythema with scaling, peripheral edema, and hyperpigmentation." Contact dermatitis is also on the list StatPearls, Cellulitis Cellulitis is unilateral, acute, flat-edged and febrile in moderate-to-severe cases
Admission criteria for cellulitis The sepsis page owns the generic SIRS criteria and the Sepsis-3 definitions Admit for "2 or more systemic inflammatory response criteria" — fever above 38 °C, heart rate above 90, respiratory rate above 20, white cell count above 12,000/mm3, white cell count below 4,000/mm3, or bandemia of 10% or more StatPearls, Cellulitis Also consider admission for failed outpatient treatment, immunocompromise, rapidly progressing erythema, inability to tolerate oral medications, or cellulitis near an indwelling device

Complications

Black-box warning — most severe: ■ Necrotizing fasciitis Report immediately
Named among cellulitis complications as rare but characterized by fevers, erythema, edema, pain out of proportion to the exam, and crepitus, requiring immediate surgical debridement. Complications of the complication: multiorgan failure, septic shock, loss of extremity, severe scarring, toxic shock, death.
Surgery is the treatment, quoted without hedging: "the treatment of necrotizing fasciitis is surgery, and no time should be wasted calling for a surgical consult. The earlier the surgery is undertaken, the better the outcome." It requires "extensive, wide debridement of all necrotic tissues," after which "the wounds must be left open and packed with wet gauze" with "daily dressing changes… mandatory" — the wound-healing page owns secondary intention and packing. On mortality, the honest answer is a range with a caveat: the source chapter prints "20 to 80%" in one section and "30 to 90%" in another, so no single figure is presented here as the number. Fournier gangrene is better characterized at about 40% despite modern treatment, rising to 88% with delayed diagnosis, and its delays beyond 12 hours significantly increase mortality. Hyperbaric oxygen is "an adjunctive treatment and not a substitute for surgical debridement," with "no evidence that this therapy improves healing or prolongs life for large wounds."
Black-box warning — most severe: ■ Toxic shock syndrome Report immediately
"Fever, hypotension, sunburn-like rash, and end-organ damage," with a "diffuse, blanching, macular erythroderma" that "desquamates one to two weeks later." Case fatality for streptococcal toxic shock "may exceed 50%," versus "less than 3%" for non-streptococcal.
The mechanism is the reason a skin infection can kill in hours: superantigen toxins "bypass the normal pathway for activation of T cells resulting in over-activation of cytokines and inflammatory cells," with organ dysfunction via capillary leak. Management is source control, aggressive fluid resuscitation, and early antibiotics including clindamycin to suppress toxin production, with intravenous immunoglobulin considered for refractory shock based on observational evidence of mortality reduction. Source control comes first, because antibiotics do not drain an abscess or debride a fascia. One deliberate omission: the numbered CDC clinical case definition was not obtained for this page, so the criteria list is not published here — what is stated is the clinical description above.
Warning: Bacteremia, sepsis and osteomyelitis Report immediately
Bacteremia may lead to endocarditis. Sepsis is diagnosed when cellulitis involves 2 or more systemic inflammatory response criteria. Osteomyelitis is infection extending to bone, requiring longer antibiotics and possibly surgery. Lymphangitis, meningitis, shock and gangrene are also listed.
The sepsis page owns the recognition criteria, the Sepsis-3 definitions, qSOFA and the bundle; this page contributes the local cue — spreading erythema plus systemic inflammatory criteria — and the link. That same two-criteria threshold is the admission trigger for cellulitis, which means the decision to admit and the decision to think about sepsis are made on the same observation. The practical consequence for the bedside is that the systemic screen at every check is not optional: temperature, heart rate, respiratory rate, white cell count and band percentage.
Warning: Treatment failure and recurrence
There is "approximately an 18% failure rate with initial antibiotic treatment," and improvement is expected "within 48 hours." Annual cellulitis recurrence is 8% to 20%, with overall recurrence "as high as 49%".
The 18% failure rate is the sourced reason the 48-hour reassessment exists, and the reassessment has three possible answers rather than one: wrong organism, wrong severity, or wrong diagnosis. Recurrence is described as preventable "with prompt treatment of cuts or abrasions, proper hand hygiene, and effective treatment of any underlying comorbidities" — plus the portal-of-entry point, which is to treat the tinea pedis between the toes. For patients with 3 to 4 episodes per year, IDSA supports prophylaxis: oral penicillin or erythromycin twice daily for 4 to 52 weeks, or intramuscular benzathine penicillin every 2 to 4 weeks.
Caution: The misdiagnosis cost
Cellulitis is "most often unilateral and rarely (if ever) presents bilaterally." The bilateral, chronic, scaling, hyperpigmented picture is venous stasis dermatitis; unilateral redness without fever or leukocytosis should raise deep vein thrombosis.
This is a complication in the sense that matters clinically: a patient treated for the wrong thing is not treated for the right one. Stasis dermatitis treated with antibiotics leaves the edema unaddressed and exposes the patient to antibiotic harms for no benefit. A deep vein thrombosis called cellulitis delays anticoagulation, and the discriminator is available at the bedside — DVT "rarely manifests with fevers or leukocytosis." And an abscess treated with antibiotics alone is undertreated, because an abscess "may need be drained to get rid of the pus." What is deliberately not stated: any percentage for how often cellulitis is misdiagnosed, because no fetched source quantifies it.

Medications for this condition

Why each class is prescribed here — every card links to its full pharmacology page.

Cephalosporins First-line
Immune / Anti-infective · cephalexin

Cephalexin is the sourced first-line for mild nonpurulent cellulitis — 500 mg every 6 hours, for at least 5 days. The disorder-side reason is a coverage argument rather than a habit: mild nonpurulent cellulitis needs streptococcal and methicillin-sensitive S. aureus cover, and the chapter asks for "antibiotics effective against streptococcal species," with MSSA also considered. MRSA cover is for purulent infection or MRSA risk, so reaching for it in a simple case is overtreatment. When the patient is systemically unwell but has no MRSA risk, the escalation stays within the class: "intravenous cefazolin, then switch to oral cephalexin." On duration, two sourced figures differ by audience and should be given honestly: the clinical chapters say at least 5 days, extended if improvement does not occur, while NHS patient information describes antibiotic tablets "usually for a week" for mild cellulitis. The number that decides between them is the reassessment: improvement is expected within 48 hours. Generation-by-generation spectrum and cross-reactivity belong to the class page.
Penicillins First-line
Immune / Anti-infective · amoxicillin

Penicillin is the answer to three separate questions on this page, and the first one is the cleanest: erysipelas is essentially a streptococcal disease, and "penicillin as monotherapy remains the first-line antibiotic used for the treatment of erysipelas." Streptococci remain penicillin-susceptible, which is why the shallowest of these infections gets the narrowest drug, and erysipelas-specific durations belong to the class page. Second, "penicillin is the preferred antibiotic for group A strep," with clindamycin added to suppress toxin. Third, it is the drug for recurrent-cellulitis prophylaxis: the 2014 IDSA guideline, as reported by StatPearls, supports "penicillin or erythromycin twice a day for 4 to 52 weeks or intramuscular benzathine penicillin every 2 to 4 weeks in patients who have 3 to 4 episodes of cellulitis per year." One more member of the class carries the heavy work: piperacillin-tazobactam is the extended-spectrum penicillin in every necrotizing regimen on this page — IDSA's, the StatPearls empiric regimens, and Fournier gangrene management — because type I infection is polymicrobial and needs gram-positive, gram-negative and anaerobic cover at once. Penicillin allergy assessment, cross-reactivity and beta-lactamase mechanics belong to the class page.
Vancomycin (Glycopeptide) First-line
Immune / Anti-infective · vancomycin

Vancomycin is what "severe" means pharmacologically on this page. It is the intravenous start when MRSA risk factors are present — "start with intravenous vancomycin and later transition to oral trimethoprim-sulfamethoxazole" — so the drug follows a defined trigger rather than a hunch. The chapter names who gets MRSA cover: "purulent cellulitis, MRSA colonization, cellulitis associated with an abscess or extensive puncture wounds, or a history of intravenous drug use." In necrotizing infection it is the usual anti-MRSA agent — "vancomycin or linezolid given the high prevalence of methicillin-resistant Staphylococcus aureus (MRSA)" — alongside piperacillin-tazobactam or a carbapenem. For the immunocompromised patient with cellulitis the sourced combination is "vancomycin with piperacillin-tazobactam or using a carbapenem." The nursing item the source itself names is monitoring: pharmacists "monitor medications with renal toxicity (vancomycin)." Level monitoring, renal dosing and infusion-reaction management belong to the class page.
Clindamycin / Lincosamides
Immune / Anti-infective · clindamycin

Clindamycin is on this page for a reason that is mechanistic rather than spectral: toxin suppression. The toxic shock chapter states it directly: "Clindamycin should also be administered to suppress toxin production," and "penicillin is the preferred antibiotic for group A strep." The argument is worth understanding rather than memorizing. The killing in severe streptococcal disease is done by superantigen exotoxins that "bypass the normal pathway for activation of T cells," and a cell-wall agent that lyses organisms does not stop toxin that is already being made — a protein-synthesis inhibitor does. That is the entire case for adding a second drug to a penicillin-susceptible organism. Clindamycin appears in all three of the empiric necrotizing-infection regimens printed by the StatPearls chapter, at 600 to 900 mg four times daily — and those three regimens carry no named guideline owner, so they are the chapter's rather than IDSA's. Clindamycin has a second, unrelated role here: the beta-lactam-allergy alternative for mild cellulitis, 300 to 450 mg every 6 hours. Clostridioides difficile risk and the D-test belong to the class page.
Carbapenems
Immune / Anti-infective · meropenem

A carbapenem is an alternative broad-spectrum backbone in necrotizing infection — the StatPearls regimens use imipenem or meropenem where others use piperacillin-tazobactam — and the disorder-side reason is the microbiology. Type I necrotizing soft tissue infection is polymicrobial: mixed aerobic and anaerobic bacteria including gram-positive species (Streptococcus, Staphylococcus aureus) and gram-negative organisms (E. coli, Pseudomonas aeruginosa), plus anaerobes (Bacteroides, Clostridium). A carbapenem covers all three groups in one agent, which is what makes it an appropriate empiric choice when you do not yet know which type you are treating and cannot afford to wait. The StatPearls regimens name specific agents — imipenem 1 g intravenously every 6 to 8 hours in one regimen and meropenem 1 g every 8 hours in another, each paired with an anti-MRSA agent and clindamycin. Fournier gangrene management lists "carbapenems" first among its broad-spectrum options, alongside piperacillin-tazobactam plus clindamycin and vancomycin, with aggressive fluid resuscitation and vasopressor support as needed. The framing that must survive every version of this: antibiotics run alongside surgery, never instead of it — urgent debridement is "the definitive and essential treatment." Carbapenem spectrum, seizure risk and stewardship belong to the class page.

Beyond medications

  • Mark the border, date it, and time it. Clinical practice involves marking the erythematous area to monitor progression. The same chapter frames it for the patient: "The clinician may mark the area of erythema, and patients should return if they notice the erythema beginning to spread." The mark converts a subjective impression into a measurement — without it, "is it spreading?" is answered from memory by whoever happens to be on shift.
  • Elevate the limb above the level of the heart. This is treatment, not comfort. Patients should "elevate the area above the level of their heart to reduce edema," and keep "the area clean and dry." Edema is both a consequence of the infection and a risk factor for the next one, which is why lymphedema is the named major risk factor for erysipelas.
  • Reassess within 24 to 48 hours, because that is when improvement is expected. "If the clinician promptly identifies cellulitis and initiates treatment with the correct antibiotic, patients can expect to notice an improvement in signs and symptoms within 48 hours." With an 18% initial treatment failure rate, the reassessment has three possible answers: wrong organism, wrong severity, or wrong diagnosis.
  • Drainage is the treatment for an abscess. An abscess "may need be drained to get rid of the pus," usually by "a small operation to make a cut in the skin." Antibiotics alone do not treat a drainable abscess, and the purulent-versus-nonpurulent split is the first branch of the whole approach.
  • In necrotizing fasciitis, surgery is the treatment, and the sentence is quoted without hedging: "the treatment of necrotizing fasciitis is surgery, and no time should be wasted calling for a surgical consult. The earlier the surgery is undertaken, the better the outcome." It requires "extensive, wide debridement of all necrotic tissues," and IDSA's own wording is that prompt surgical consultation is recommended for patients with aggressive infections. Delayed surgery is a named poor prognostic factor, and in Fournier gangrene delays beyond 12 hours significantly increase mortality.
  • After debridement, "the wounds must be left open and packed with wet gauze. Daily dressing changes are mandatory." Fournier management adds wide excision of all necrotic tissue, typically staged procedures, vacuum-assisted closure dressing, and testicular preservation where possible. The wound-healing page owns healing by secondary intention, packing technique and negative-pressure wound therapy.
  • Hyperbaric oxygen is an adjunct and not a treatment. Quoted: it is "an adjunctive treatment and not a substitute for surgical debridement," and "there is no evidence that this therapy improves healing or prolongs life for large wounds," though it may benefit small wounds in a stable patient. Present it with its own hedge attached.
  • Prevention and recurrence, with a specific target. Recurrence is preventable "with prompt treatment of cuts or abrasions, proper hand hygiene, and effective treatment of any underlying comorbidities" — and the sourced portal-of-entry point adds treating the tinea pedis between the toes. Patient-level prevention (NHS): "keeping skin clean and well moisturised," "cleaning any cuts or wounds and using antiseptic cream," "wearing appropriate clothing and footwear," and "wearing gloves if working outside." At 3 to 4 episodes per year, antibiotic prophylaxis becomes an option (IDSA 2014, as reported by StatPearls).

Nursing considerations

The RN-specific layer — each action paired with the reason it matters.

Assessment & monitoring
Mark the border with a pen and write the date and time on the skin. Reassess against the mark, not against your memory.
Why: Marking is the sourced method of monitoring progression, and improvement is expected within 48 hours. With an 18% initial-treatment failure rate, "is it spreading?" is a question that has to be answerable by whoever is on the next shift.
Ask about pain out of proportion at every check, and palpate beyond the marked border.
Why: "Suspicion should be high for necrotizing fasciitis in intense pain," and tenderness beyond the erythematous border maps the fascial spread the skin has not caught up with. Both findings are available before any appearance change, which is the whole point of looking for them.
Treat a red area that has stopped hurting or gone numb as deterioration, not improvement.
Why: Fascial destruction takes out cutaneous nerves, producing "dysesthesia or paresthesia" and then "anesthesia… in some areas." This is the most counterintuitive sign on the page, and it is easy to chart as progress if nobody has been taught it.
Run the systemic screen at every check: temperature, heart rate, respiratory rate, white cell count and band percentage.
Why: Two or more systemic inflammatory response criteria is the sourced admission threshold, so this screen is what decides inpatient versus outpatient.
Check laterality and chronicity before accepting the diagnosis. Bilateral, chronic, scaling and hyperpigmented is stasis dermatitis; unilateral without fever or leukocytosis should raise deep vein thrombosis.
Why: Cellulitis "is most often unilateral and rarely (if ever) presents bilaterally," and deep vein thrombosis "rarely manifests with fevers or leukocytosis." Both errors have real costs: unnecessary antibiotics in one direction, delayed anticoagulation in the other.
For a wound in the perineal, scrotal or genital region, hold a lower threshold: pain disproportionate to visible findings, crepitus, or foul-smelling discharge.
Why: Fournier gangrene's early signs — itching, tenderness, edema, erythema — are easily confused with cellulitis, it is "rapidly progressive," mortality is about 40%, and delays beyond 12 hours significantly increase it.
Interventions & safety
Call the surgeon on the clinical picture. Do not wait for a LRINEC score, a CT, or any other test.
Why: Quoted twice: "the diagnosis of NSTIs is still primarily clinical," and "no lab or imaging test should delay surgical intervention." A low LRINEC score in a patient with pain out of proportion does not rule this out — the score can raise suspicion and is never permitted to lower it.
Speak up. The sourced instruction to nurses is explicit: recognize that the patient is critically ill or in pain, and consult the surgeon as soon as possible.
Why: Quoted: "the nurse is often the first to recognize that the patient is critically ill or in pain. Nurses should be knowledgeable about necrotizing fasciitis and consult the surgeon as soon as possible." Delayed surgery is a named poor prognostic factor, and it is the only one on that list the team controls.
Elevate the limb above the level of the heart, and keep the area clean and dry.
Why: It is a sourced treatment rather than a comfort measure — elevation reduces the edema that both results from the infection and predisposes to the next one. Lymphatic edema is the named major risk factor for erysipelas.
Expect a scalpel for a fluctuant lesion. Antibiotics alone do not treat a drainable abscess.
Why: An abscess "may need be drained to get rid of the pus," and the purulent-versus-nonpurulent split is the first branch of the approach. An abscess on antibiotics alone is an undertreated abscess.
After debridement, leave the wound open, pack it with wet gauze, and do the daily dressing changes.
Why: Quoted: "with wide debridement, the wounds must be left open and packed with wet gauze. Daily dressing changes are mandatory." Fournier management adds staged procedures and vacuum-assisted closure. The wound-healing page owns secondary intention and negative-pressure therapy.
Expect clindamycin alongside penicillin in documented group A streptococcal disease, and know why.
Why: "Penicillin is the preferred antibiotic for group A strep," and "clindamycin should also be administered to suppress toxin production." A cell-wall agent kills the organism but does not stop the superantigen toxin already being made; a protein-synthesis inhibitor does.
Patient teaching
Give the return precautions verbatim: come back if the redness starts to spread or is not responding to antibiotics, if fevers persist, if significant bullae develop, or if the pain worsens.
Why: This is the sourced list, and the last item is the one that matters most, because worsening pain is how necrotizing infection announces itself before the skin changes. NHS adds when to call 999: a very high temperature or feeling hot, cold or shivery, a fast heartbeat or fast breathing, purple patches on the skin, or confusion.
Say that improvement should be visible within 24 to 48 hours, and that if it is not, the plan changes rather than continues.
Why: The sourced expectation is improvement within 48 hours on the correct antibiotic, and the initial-treatment failure rate is about 18%. A patient who expects a slow grind will wait a week before calling, which is exactly the delay the reassessment rule exists to prevent.
Teach elevation above heart level and keeping the area clean and dry as part of the treatment, alongside taking the antibiotic as prescribed.
Why: Both are sourced instructions, and framing elevation as treatment rather than as advice is what gets it done. Good hand hygiene and adequately cleaning any future abrasions are on the same list, because the next episode starts at the next break in the skin.
Treat the tinea pedis. Look between the toes and name it as the doorway.
Why: "Fissures between toes" are explicitly on the portal-of-entry list, and recurrence is described as preventable with prompt treatment of skin breaks and effective treatment of underlying comorbidities. It is the commonest unrecognized cause of a recurrent leg cellulitis, and it is cheap to fix.
For a patient with 3 to 4 episodes a year, raise prophylaxis as a guideline-supported option.
Why: IDSA supports oral penicillin or erythromycin twice daily for 4 to 52 weeks, or intramuscular benzathine penicillin every 2 to 4 weeks at that frequency. Annual recurrence runs 8% to 20% with overall recurrence as high as 49%, so this is a common situation rather than an unusual one.
Give the everyday prevention list concretely: keep skin clean and well moisturised, clean any cut and use antiseptic cream, wear appropriate clothing and footwear, and wear gloves when working outside — plus prompt treatment of cuts, hand hygiene and treating tinea pedis between the toes.
Why: This is the sourced patient-level prevention set, and it is specific enough to act on. Each item targets the same thing the whole page turns on — keeping the skin barrier intact, because the portal of entry is the entire etiology.

How a real nurse thinks

The clinical-judgment loop, worked for a typical presentation — reasoning, not reference.

  1. 1
    Recognize cues

    At the first visit, the cues all point one way. Unilateral, which matters because cellulitis "is most often unilateral and rarely (if ever) presents bilaterally." Flat and poorly demarcated, which is cellulitis rather than erysipelas. No fluctuance or purulence, so this is the nonpurulent arm of the algorithm. And fissures between the toes, which is on the sourced portal-of-entry list. His systemic screen shows fewer than two inflammatory criteria: temperature 37.8, heart rate 88, respiratory rate 18, white cells 11,200. At 18 hours everything has changed, and the changes are not about appearance. Pain far beyond what the leg looks like. Tenderness several centimetres past the mark. A patch that is dusky and slightly numb. Crepitus. Temperature 39.1, heart rate 126, blood pressure 92/58.

  2. 2
    Analyze cues

    The first visit was a correct call. Mild nonpurulent cellulitis by IDSA — typical presentation without systemic signs — and fewer than two systemic inflammatory response criteria, which is below the sourced admission threshold. Cephalexin 500 mg every 6 hours is the sourced first-line for exactly that tier, because mild nonpurulent cellulitis needs streptococcal and methicillin-sensitive staphylococcal cover, not MRSA cover. The 18-hour presentation is a different diagnosis, and the giveaway is that the worst findings are not visual. Pain out of proportion is the sourced lead sign for necrotizing infection. Tenderness beyond the border maps fascial spread the skin has not caught up with. The numb patch is nerve destruction, not improvement. Crepitus is subcutaneous gas. And he now meets multiple systemic criteria with hypotension. Score the labs if you like — C-reactive protein 210 (4 points), white cells 19,000 (1), hemoglobin 10.4 (2), sodium 130 (2), creatinine 1.9 (2), glucose 260 (1) gives a LRINEC of 12, well past the 8 that "represents a 75% risk." But the score is confirmation, not permission. "The diagnosis of NSTIs is still primarily clinical," and a score of 3 would not have changed a single thing about what happens next.

  3. 3
    Prioritize

    The first priority is a phone call, not a test. "The treatment of necrotizing fasciitis is surgery, and no time should be wasted calling for a surgical consult." Delayed surgery is a named poor prognostic factor and it is the only one on that list anybody in this room can change. Second, resuscitate: large-bore access, fluids for a blood pressure of 92/58, blood cultures and lactate. Third, broad empiric antibiotics — alongside the surgeon, never instead of one. Fourth, prepare him and the operating room. What is explicitly not a priority: imaging first. CT has "greater sensitivity than plain film" and plain films have "no value," but "no lab or imaging test should delay surgical intervention," and imaging should never delay surgery in obvious cases. This one is obvious.

  4. 4
    Generate solutions

    Anticipate immediate surgical exploration and wide debridement of all necrotic tissue, possibly staged, with the wound left open and packed with wet gauze and mandatory daily dressing changes. Anticipate the surgeon may perform the finger test — "the necrotic tissue can be penetrated with little resistance." Anticipate broad empiric cover: vancomycin or linezolid plus piperacillin-tazobactam or a carbapenem, plus clindamycin — broad, because type I infection is polymicrobial with gram-positives, gram-negatives and anaerobes together, and we do not yet know the type. Anticipate clindamycin being added if group A streptococcus is documented, because "penicillin is the preferred antibiotic for group A strep," and clindamycin is there to suppress toxin production rather than to broaden the spectrum. Anticipate watching for toxic shock — hypotension, a diffuse blanching sunburn-like rash, and renal, hepatic or coagulation involvement — where "case fatality… may exceed 50%" for the streptococcal form. Anticipate critical care, and an interprofessional team that the source names: general surgery, infectious disease, intensive care, nephrology, radiology and intensive care unit nurses.

  5. 5
    Take action

    Call the surgeon first and say the words that carry the diagnosis: pain out of proportion, tenderness beyond the marked border, crepitus, a numb dusky patch, and hypotension. Do not lead with the laboratory values. Establish large-bore access, send blood cultures and lactate, and start fluid resuscitation for the blood pressure. Get the broad-spectrum antibiotics in, and be explicit in handoff that they are adjunctive. Keep him nil by mouth and prepare him for theatre. Notify critical care. Document the border mark from 18 hours ago and where the tenderness now extends to, because that comparison is the clearest evidence of progression anyone will have. And say out loud, to whoever needs to hear it, that a low score would not have changed this — the sourced nursing role here is exactly this: the nurse is often the first to recognize that the patient is critically ill or in pain… [and] should consult the surgeon as soon as possible.

  6. 6
    Evaluate

    Evaluate against the thing that actually changes outcome, which is time to the operating room — "the earlier the surgery is undertaken, the better the outcome," and in the Fournier literature delays beyond 12 hours significantly increase mortality. Postoperatively, evaluate the wound at each mandatory daily dressing change and be alert to the need for further staged debridement. Watch for toxic shock: hypotension, a diffuse blanching macular erythroderma that will desquamate at one to two weeks, and renal, hepatic or coagulation involvement. Management there is source control, aggressive fluid resuscitation, and early antibiotics including clindamycin, with intravenous immunoglobulin considered for refractory shock. On prognosis, be honest about the uncertainty: the source chapter prints both "20 to 80%" and a higher range for necrotizing fasciitis mortality, so this page does not present one figure as the number — the useful message is that outcome depends heavily on how quickly he reached surgery. And close the loop on the first visit, which was not an error: he was correctly classified as mild nonpurulent cellulitis and given the sourced first-line agent. What made the difference was the marked border, the return precautions that named worsening pain, and a patient who came back at 18 hours instead of waiting for the 48-hour appointment.

Scenario — you’re the nurse

Work each question before revealing the answer. Rationales explain the wrong options too.

Urgent care clinic, then the emergency department 18 hours later

A 58-year-old with type 2 diabetes presents with a red, painful left lower leg that started yesterday. He has macerated, fissured skin between the fourth and fifth toes on that foot.

Leg — unilateral, flat and poorly demarcated warm, tender erythema over the shin
Vitals — temperature 37.8 °C · HR 88 · RR 18 · WBC 11,200/mm3
Assessment — border marked with a pen and dated; no fluctuance, no purulence
Plan — cephalexin 500 mg every 6 hours, leg elevated above heart level, reassess at 48 hours
At 18 hours he returns — pain far beyond what the leg looks like; tenderness several centimetres past the mark; a dusky, slightly numb patch over the shin; crepitus; temperature 39.1 °C · HR 126 · BP 92/58
Q1 Multiple choice
A patient with a red, painful leg reports pain far out of proportion to the appearance of the skin, and tenderness extends several centimetres beyond the erythematous border. The LRINEC score is 4. What does the nurse do?
  1. A. Reassure the patient, since a LRINEC under 6 makes necrotizing fasciitis unlikely
  2. B. Contact the surgeon immediately, because the diagnosis is primarily clinical and no test may delay surgical intervention
  3. C. Order a CT scan and await the result before escalating
  4. D. Continue oral antibiotics and reassess at 48 hours
Reveal answer & rationale
Answer: B
Quoted twice in the source: "the diagnosis of NSTIs is still primarily clinical," and "no lab or imaging test should delay surgical intervention" (B). Option A is the killed claim: a score below 6 does not exclude necrotizing fasciitis, and the score is permitted to raise suspicion but never to lower it below the clinical picture. Option C delays the one intervention that changes outcome — "the treatment of necrotizing fasciitis is surgery, and no time should be wasted calling for a surgical consult" — and imaging should never delay surgery in obvious cases. Option D treats a surgical emergency as a cellulitis. The two findings described are the two strongest sourced signs: pain out of proportion, and tenderness beyond the border, which maps fascial spread the skin has not caught up with.
Q2 Select all that apply
Which findings distinguish cellulitis from its mimics? Select all that apply.
  1. A. Cellulitis is most often unilateral and rarely, if ever, bilateral
  2. B. Deep vein thrombosis rarely presents with fever or leukocytosis
  3. C. Venous stasis dermatitis is bilateral, chronic, scaling and hyperpigmented
  4. D. Erysipelas has raised, well-demarcated borders while cellulitis is flat with ill-defined borders
  5. E. Bilateral leg redness with warmth confirms bilateral cellulitis
Reveal answer & rationale
Answer: A, B, C, D
Cellulitis "is most often unilateral and rarely (if ever) presents bilaterally" (A). Deep vein thrombosis presents with unilateral tenderness, erythema, warmth and edema but "rarely manifests with fevers or leukocytosis," and needs ultrasound confirmation (B). Venous stasis dermatitis is "a long-standing, bilateral, inflammatory dermatosis" with "erythema with scaling, peripheral edema, and hyperpigmentation" (C). And erysipelas shows "elevation of the affected skin" and "well-demarcated borders," while cellulitis has poorly demarcated borders and appears flat (D). Option E is the error the other four exist to prevent — bilateral leg redness is almost never bilateral cellulitis, and treating stasis dermatitis with antibiotics leaves the edema unaddressed.
Q3 Multiple choice
A patient has a fluctuant, purulent lesion on the forearm with surrounding erythema but no systemic signs. What is the recommended treatment?
  1. A. Oral cephalexin for at least 5 days
  2. B. Incision and drainage
  3. C. Intravenous vancomycin
  4. D. Topical antibiotic and warm compresses only
Reveal answer & rationale
Answer: B
An abscess "may need be drained to get rid of the pus" (B). The purulent-versus-nonpurulent split is the first branch of the whole approach. Option A is the correct answer to a different question — cephalexin 500 mg every 6 hours is the sourced first-line for mild nonpurulent cellulitis. Option C is for MRSA risk, where the chapter says to "start with intravenous vancomycin." Option D undertreats. A drainable abscess needs a scalpel, not a script.
Q4 Multiple choice
A patient with documented group A streptococcal necrotizing fasciitis is started on penicillin. Clindamycin is added. The rationale is:
  1. A. Clindamycin broadens gram-negative coverage
  2. B. Clindamycin suppresses toxin production, which a cell-wall agent cannot do
  3. C. Clindamycin replaces the need for surgical debridement
  4. D. Clindamycin is used because the patient is likely penicillin-allergic
Reveal answer & rationale
Answer: B
"Penicillin is the preferred antibiotic for group A strep," and "clindamycin should also be administered to suppress toxin production" (B). The mechanism is the argument: the killing in severe streptococcal disease is done by superantigen exotoxins that "bypass the normal pathway for activation of T cells," and a cell-wall agent that lyses the organism does not stop toxin already being made — a protein-synthesis inhibitor does. Option A misstates the spectrum. Option C is the dangerous one: "the treatment of necrotizing fasciitis is surgery," and antibiotics run alongside debridement, never instead of it. Option D confuses this with clindamycin's separate role as the beta-lactam-allergy alternative for mild cellulitis at 300 to 450 mg every 6 hours.
Q5 Multiple choice
A patient treated for cellulitis returns at 48 hours with no improvement. Which statement should guide the nurse?
  1. A. "Cellulitis usually takes a week to respond, so continue the current antibiotic."
  2. B. "Improvement is expected within 48 hours, and about 18% of initial treatments fail, so the diagnosis, the organism and the severity all need reconsidering."
  3. C. "Failure to improve means the patient needs a longer course of the same drug."
  4. D. "A repeat blood culture will identify the problem."
Reveal answer & rationale
Answer: B
Quoted: patients "can expect to notice an improvement in signs and symptoms within 48 hours" on the correct antibiotic, and there is "approximately an 18% failure rate with initial antibiotic treatment" (B). The reassessment has three possible answers rather than one — wrong organism, wrong severity tier, or wrong diagnosis entirely, with deep vein thrombosis, stasis dermatitis, contact dermatitis and an undrained abscess all on the list. Options A and C both continue a failing plan, and option A contradicts the sourced 48-hour expectation. Option D misuses cultures, which are recommended "only" for immunocompromised patients, immersion injury, animal bites or systemic signs — not routinely.

Common questions

What causes cellulitis & necrotizing fasciitis?
Common causes and risk factors include any break in the skin — this is the whole etiology. "skin injuries, surgical incisions, intravenous site punctures, fissures between toes, insect bites, animal bites, and other skin infections", chronic or untreated tinea pedis — listed as a risk factor in its own right, and the commonest unrecognized doorway into a leg cellulitis. it is a target for preventing the next episode rather than an incidental finding, diabetes mellitus — a cellulitis risk factor, a necrotizing fasciitis risk factor, and present in 20% to 70% of fournier gangrene cases, venous insufficiency, peripheral arterial disease and lymphedema. lymphatic edema is named the "major risk factor" for erysipelas specifically, alcohol use disorder and liver cirrhosis — "the majority of patients [with necrotizing fasciitis] have diabetes and a history of alcoholism," and chronic alcohol use appears in 25% to 50% of fournier cases, and others.
Which findings should a nurse report immediately in cellulitis & necrotizing fasciitis?
Report immediately: Fever, malaise and fatigue with a spreading red limb, Excruciating pain out of proportion to what the skin looks like, Tenderness to palpation beyond the erythematous border, Crepitus, An area that has gone numb, or where pain has stopped, and others. These signal deterioration that needs rapid intervention.
Which medications are used to treat cellulitis & necrotizing fasciitis?
Commonly prescribed drug classes include Cephalosporins, Penicillins, Vancomycin (Glycopeptide), Clindamycin / Lincosamides, Carbapenems — each is covered in depth in the pharmacology course.
Does a low LRINEC score rule out necrotizing fasciitis?
No, and this is the main reason to teach the score at all. The components are C-reactive protein, white cell count, hemoglobin, sodium, creatinine and glucose, and the performance figures are real: "a score of 6 has a positive predictive value of 92% and a negative predictive value of 96%. A score of 8 or greater represents a 75% risk of necrotizing infection." But the source immediately qualifies them: "the diagnosis of NSTIs is still primarily clinical," and "no lab or imaging test should delay surgical intervention." A patient with pain out of proportion, tenderness beyond the erythematous border, crepitus or a numb dusky patch goes to a surgeon whatever the score says. The same rule covers imaging: computed tomography has "greater sensitivity than plain film," plain X-rays have "no value," and imaging should never delay surgery in obvious cases. The score can raise your suspicion. It is never allowed to lower it.
Is "dirty dishwater fluid" a sign of necrotizing fasciitis?
It is widely taught, and it appears in no source fetched for this page — so it is not taught here. What the fetched literature actually describes at operation is the finger test: "sometimes, under local anesthesia, one may probe the area with a finger for signs of necrotizing tissue. In most cases, the necrotic tissue can be penetrated with little resistance." Histopathology shows "extensive superficial fascial necrosis" with thrombosed vessels. The sourced bedside findings, which are what a nurse actually works from, are pain out of proportion to the examination, tenderness beyond the erythematous border, crepitus, skin turning "reddish-purple to bluish-gray" and becoming "swollen, shiny, and warm," bullae and cutaneous gangrene with skin breakdown at 3 to 5 days, and dysesthesia, paresthesia and then anesthesia. Those are the findings that get a surgeon called, and none of them requires being in an operating room to observe.
Why do erysipelas and cellulitis get different first-line drugs?
Because they are different depths with different organisms, even though they look like variations on one theme. Erysipelas involves "the upper dermis and superficial lymphatic system" and is essentially a streptococcal disease. Streptococci remain penicillin-susceptible, so the guideline's mild nonpurulent tier asks for an agent active against streptococci, which is penicillin. Cellulitis is deeper — dermis and subcutaneous tissue — and is caused by Streptococcus pyogenes and Staphylococcus aureus, so mild nonpurulent disease is treated with cephalexin 500 mg every 6 hours for at least 5 days, which covers streptococci and methicillin-sensitive staphylococci. The depth difference is also visible at the bedside: erysipelas is raised with a sharply demarcated border because the superficial lymphatics are anatomically bounded; cellulitis is flat with a blurry edge because the deeper tissue is not.

Sources

Reviewed by Hae Suk Lee, RN

Educational summary for nursing students. Scenarios are fictional teaching cases. Always verify against current guidelines and your institution's protocols before acting in practice. Not medical advice.

Bookmark LearnDrugs.com?

Your saved pages are kept in this browser. Add LearnDrugs.com to your browser’s bookmarks to get back to them in one click.

Drag this link to your bookmarks bar: LearnDrugs.com

Or press Ctrl + D to bookmark the page you’re on.